Results 26 - 50 from 80 for "zentiva"
-
Zentiva Gets Antitrust Clearance to Buy Solacium Brand from A&D Pharma
05.28.2019
Romania's antitrust body has cleared the deal whereby generics manufacturer Zentiva, owned by Advent International, took over the Romanian food supplement brand Solacium from A&D Pharma, owned by Dr. more
-
Zentiva Net Profit Nearly Triples in 1Q, To RON32.5M
05.15.2019
Generics manufacturer Zentiva on Wednesday reported a net profit of RON32.5 million for the first quarter, nearly triple compared with the RON12 million net profit posted in the same period of 2018. more
-
Zentiva Invests Over RON27M In Generic Drug Production In 2018
05.02.2019
-
Zentiva Net Profit Nearly Triples in 2018, to RON247M
02.28.2019
Generics manufacturer Zentiva on Thursday reported a net profit of RON247 million for 2018, nearly triple compared with a profit of RON86 million in 2017. more
-
Czech Zentiva Launches Mandatory Takeover Bid For Remaining 6.7% Stake In Zentiva Bucharest
12.13.2018
Czech group Zentiva is launching a mandatory takeover bid for the remaining 6.7% stake in drugmaker Zentiva Bucharest (the former Sicomed), at a price of nearly RON105 million, which enables Zentiva more
-
Zentiva Pharmaceutical Plant Could Go To Indian Company
03.14.2018
The generics division of French-held Sanofi, which includes the Zentiva pharmaceutical company with its plant in Romania (the former Sicomed), as well, is being courted by India’s Torrent more
-
Generics Manufacturer Zentiva Posts Net Profit of RON43M in 1H/2017
08.01.2017
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, on Tuesday reported a net profit of RON43 million for the first six months of 2017, higher than the RON32.4 million profit more
-
Zentiva Posts 10% Higher Turnover, Of RON110.2M, 9% Lower Operating Profit In 1Q/2017
05.12.2017
-
Zentiva Bucharest Pays Out Dividends At 6.5% Yield
04.28.2017
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, will pay dividends of RON65 million from last year’s profit of RON73 million, the company said Friday. more
-
Zentiva Plans To Pay Out Dividends At 8% Yield, Targets RON16M Investments In 2017
03.23.2017
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, plans to pay out a gross dividend of RON0.155 per share, which equals a yield of nearly 8%, considering the current price more
-
Zentiva Posted Turnover Of RON415M, Net Profit Of RON72M In 2016
02.15.2017
-
Zentiva Profit Up 36% To RON52.5M In January-September
11.14.2016
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported a net profit of RON52.5 million in January-September 2016, up 36% against the year-earlier period, the company more
-
Zentiva Profit Up 81% To RON32.4M In January-June
08.02.2016
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported a net profit of RON32.4 million in January-June 2016, up 81% against the year-earlier period. more
-
Zentiva Profit Soared 68% To RON12M In 1Q/2016
05.18.2016
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported a profit of RON12 million in January-March 2016, up 68% against the year-earlier period. more
-
Zentiva To Pay RON40M In Dividends For 2015
05.03.2016
Romanian drugmaker Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, will pay dividends totaling RON40 million for 2015, the company said in a statement. more
-
Zentiva Mulls Paying RON40M In Dividends For 2015
03.25.2016
Romanian drugmaker Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, wants to pay dividends of approximately RON0.0959 per share to shareholders, totaling RON40 million. more
-
Zentiva’s Shares Down 3% After BET-XT Exit Announcement
09.08.2015
The shares of Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, decreased 3% on the Bucharest Stock Exchange since September 1 announcement on the company’s shares being more
-
Zentiva 1H Turnover Up 4%, Profit Down 34%, To RON18M
08.12.2015
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi posted a net turnover of RON209 million (EUR47 million) in the first half of the year, up 4% from the same period last more
-
Zentiva Romania Sees Lower Profit In First Quarter
05.17.2015
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported net profit of 12 million lei (EUR2.7 million) for the first quarter of 2015, down 15.5% compared with RON14.2 more
-
Zentiva To Pay Dividends Of RON54.24M From 2014 Net Profit
04.30.2015
Shareholders of Romanian drugmaker Zentiva Bucharest (SCD.RO) Thursday approved the payment of dividends worth RON54.24 million, from 2014 net profit and, and of RON15.75 million from distributable more
-
Zentiva 2014 Net Profit Rises 65% to RON61.5M
02.13.2015
Romanian drugmaker Zentiva Bucharest (SCD.RO) posted a preliminary net profit of 61.5 million lei (EUR13.8 million) for 2014, up 65.3% compared with the previous year, following a significant increase more
-
Zentiva 9-Month Revenue Up 33%, To RON319.7M
11.14.2014
Pharmaceutical company Zentiva Romania (SCD.RO) posted a 33% revenue growth in the first nine months of the year, to RON319.7 million from RON240 million in the same period last year, and its net more
-
Zentiva Posts 24% Growth In Turnover In 1H, Profit Down 4%
08.12.2014
Pharmaceutical company Zentiva Romania (SCD.RO) posted a 24.4% growth in turnover in the first half of the year, to RON200.1 million (EUR44.8 million), and a 4% drop in net profit, to RON27.2 million more
-
Exports Up To 25% Of Zentiva Bucharest’s Production
06.12.2014
Exports reached 25% of the production of Zentiva (SCD.RO) plant in Bucharest, a unit of French pharmaceutical group Sanofi, frm just 15% in 2013. more
-
Zentiva Romania 1Q Sales Up Nearly 39% To RON102.2M
05.15.2014
Drugmaker Zentiva Romania (SCD.RO) Thursday said its sales surged 38.7% to 102.2 million lei (EUR22.7 million) in the first quarter of 2014, from RON73.6 million in the year-earlier period. more